Dataset Information

Autocrine Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts

ABSTRACT: Fibroblast to myofibroblast conversion is a major driver of tissue remodeling in organ fibrosis. Several distinct lineages of fibroblasts support homeostatic tissue niche functions, yet, specific activation states and phenotypic trajectories of fibroblasts during injury repair have remained unclear. Here, we combined spatial transcriptomics, longitudinal single-cell RNA-seq and genetic lineage tracing to study fibroblast fates during mouse lung regeneration. We discovered a transitional fibroblast state characterized by high Sfrp1 expression, derived from both Tcf21-Cre lineage positive and negative cells. Sfrp1+ cells appeared early after injury in peribronchiolar, adventitial and alveolar locations and preceded the emergence of myofibroblasts. We identified lineage specific paracrine signals and inferred converging transcriptional trajectories towards Sfrp1+ transitional fibroblasts and Cthrc1+ myofibroblasts. Tgfβ1 downregulated Sfrp1 in non-invasive transitional cells and induced their switch to an invasive Cthrc1+ myofibroblast identity. Finally, using loss of function experiments we show that autocrine Sfrp1 directly inhibits fibroblast invasion by regulating the RhoA pathway. In summary, our study reveals the convergence of spatially and transcriptionally distinct fibroblast lineages into transcriptionally uniform myofibroblasts and identifies Sfrp1 as an autocrine inhibitor of fibroblast invasion during early stages of fibrogenesis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE207561 | GEO | 2023/11/14

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Pericryptal myofibroblasts in the colon and rectum play an important role in regulating the normal colorectal stem cell niche and facilitating tumour progression. Myofibroblasts have previously mostly been distinguished from normal fibroblasts only by the expression of Î± smooth muscle actin (Î±SMA). We now identify AOC3, a surface monoamine oxidase, as a new marker of myofibroblasts by showing that it is the target protein of the myofibroblast reacting monoclonal antibody (mAb), PR2D3. The normal and tumour tissue distribution and the cell line reactivity of AOC3 match that expected for myofibroblasts. We have shown that the surface expression of AOC3 is sensitive to digestion by trypsin and collagenase and that anti-AOC3 antibodies can be used for FACS sorting of myofibroblasts obtained by non-enzymatic procedures. Whole genome microarray mRNA expression profiles of myofibroblasts and skin fibroblasts revealed four additional genes that are significantly expressed differentially between these two cell types; NKX2-3 and LRRC17 are expressed in myofibroblasts and SHOX2 and TBX5 in skin fibroblasts. Transforming Growth Factor Î² (TGFÎ²) substantially down-regulated AOC3 expression in myofibroblasts but not in skin fibroblasts, in which it dramatically increased the expression of Î±SMA. A knockdown of NKX2-3 in myofibroblasts caused a decrease of myofibroblast-related gene expression and an increased expression of the fibroblast associated gene, SHOX2, suggesting that NKX2-3 is a key mediator for maintaining myofibroblast characteristics. Our results show that colorectal myofibroblasts, as defined by the expression of AOC3, NKX2-3 and other markers, are a distinctly different cell type from TGFÎ² activated fibroblasts. colorectal myofibroblast specific markers and expression profiles were sought by comparing four primary myofibroblast cultures to a panel of four dermal and foreskin fibroblast cell lines Four primary myofibroblast cultures established from adult human colon compared to four skin fibroblast cell lines to identify intestinal myofibroblast specific markers

Project description:Cardiomyopathy is characterized by the deposition of extracellular matrix by activated resident cardiac fibroblasts, called myofibroblasts. A current lack of therapeutic approaches to blunt the development of pathological fibrosis and ventricle chamber stiffening that ultimately leads to heart failure necessitates the investigation of the mechanisms that underlie myofibroblast activation. We previously observed that increased degradation of p53 occurs during the cardiac fibroblast expansion phase that acutely follows pressure overload. We created tissue-specific mouse models to delete p53 in quiescent resident cardiac fibroblasts and in activated myofibroblasts, then evaluated consequences to cardiac physiology, cellular biology, and fibrotic remodeling. We then performed RNA sequencing to further elucidate the effects of p53 deletion in cardiac fibroblasts on gene expression at the single cell level. We confirmed these results with a series of in vitro experiments in primary mouse cardiac fibroblasts. Results - Here, we demonstrate that p53 knockout in resident cardiac fibroblasts significantly accelerates proliferation and temporarily insulates the heart from fibrotic remodeling and functional decline in response to pressure overload, but ultimately results in a more deleterious phenotype than in wildtype animals. Conversely, p53 knockout in activated myofibroblasts does not result in a delay in functional loss, and is uniformly deleterious to the heart. Single-cell RNA sequencing revealed that p53 knockout is associated with the development of constitutively mitotic fibroblasts, and increased recruitment of fibroblasts into a main activation trajectory that involves four states: quiescent, early transitional, late transitional, and fully activated. A quiescent, functionally specialized vascular support fibroblast population that is ubiquitous in the wildtype animal is additionally recruited into activation in the p53 knockout condition, resulting in the eventual extreme functional decline seen in these animals. In vitro experimentation using viral deletion of p53 supports these findings - quiescent fibroblasts lacking p53 are resistant to activation, but activated myofibroblasts lacking p53 do not reverse their activation. This was found to be due to parallel hyperactivation of Cdkn2a/Rb1-mediated G1 cell cycle arrest in the p53 knockout condition, which was supported by in vivo studies. Conclusions - These data establish p53 as a major regulator of the myofibroblast activation response to pressure overload. Moreover, the single-cell studies establish an activation trajectory for resident cardiac fibroblasts, and elucidate the fundamental importance of clinical intervention prior to irreversible myofibroblast activation seen in chronic stages of pressure overload.

Dataset Information

Autocrine Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets